Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1058451

Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine


D’Amario, Domenico; Gowran, Aoife; Canonico, Francesco; Castiglioni, Elisa; Rovina, Davide; Santoro, Rosaria; Spinelli, Pietro; Adorisio, Rachele; Amodeo, Antonio; Perrucci, Gianluca et al.
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine // Journal of clinical medicine, 7 (2018), 9; E291, 36 doi:10.3390/jcm7090291 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1058451 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine

Autori
D’Amario, Domenico ; Gowran, Aoife ; Canonico, Francesco ; Castiglioni, Elisa ; Rovina, Davide ; Santoro, Rosaria ; Spinelli, Pietro ; Adorisio, Rachele ; Amodeo, Antonio ; Perrucci, Gianluca ; Borovac, Josip Anđelo ; Pompilio, Giulio ; Crea, Filippo

Izvornik
Journal of clinical medicine (2077-0383) 7 (2018), 9; E291, 36

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Duchenne muscular dystrophy ; cardiomyopathy ; cardiomyopathy in muscular dystrophy ; dilated ; dystrophin ; heart failure ; personalized medicine

Sažetak
Duchenne's muscular dystrophy is an X-linked neuromuscular disease that manifests as muscle atrophy and cardiomyopathy in young boys. However, a considerable percentage of carrier females are often diagnosed with cardiomyopathy at an advanced stage. Existing therapy is not disease-specific and has limited effect, thus many patients and symptomatic carrier females prematurely die due to heart failure. Early detection is one of the major challenges that muscular dystrophy patients, carrier females, family members and, research and medical teams face in the complex course of dystrophic cardiomyopathy management. Despite the widespread adoption of advanced imaging modalities such as cardiac magnetic resonance, there is much scope for refining the diagnosis and treatment of dystrophic cardiomyopathy. This comprehensive review will focus on the pertinent clinical aspects of cardiac disease in muscular dystrophy while also providing a detailed consideration of the known and developing concepts in the pathophysiology of muscular dystrophy and forthcoming therapeutic options.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Josip Anđelo Borovac (autor)

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com www.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

D’Amario, Domenico; Gowran, Aoife; Canonico, Francesco; Castiglioni, Elisa; Rovina, Davide; Santoro, Rosaria; Spinelli, Pietro; Adorisio, Rachele; Amodeo, Antonio; Perrucci, Gianluca et al.
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine // Journal of clinical medicine, 7 (2018), 9; E291, 36 doi:10.3390/jcm7090291 (međunarodna recenzija, pregledni rad, znanstveni)
D’Amario, D., Gowran, A., Canonico, F., Castiglioni, E., Rovina, D., Santoro, R., Spinelli, P., Adorisio, R., Amodeo, A. & Perrucci, G. (2018) Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine. Journal of clinical medicine, 7 (9), E291, 36 doi:10.3390/jcm7090291.
@article{article, author = {D’Amario, Domenico and Gowran, Aoife and Canonico, Francesco and Castiglioni, Elisa and Rovina, Davide and Santoro, Rosaria and Spinelli, Pietro and Adorisio, Rachele and Amodeo, Antonio and Perrucci, Gianluca and Borovac, Josip An\djelo and Pompilio, Giulio and Crea, Filippo}, year = {2018}, pages = {36}, DOI = {10.3390/jcm7090291}, chapter = {E291}, keywords = {Duchenne muscular dystrophy, cardiomyopathy, cardiomyopathy in muscular dystrophy, dilated, dystrophin, heart failure, personalized medicine}, journal = {Journal of clinical medicine}, doi = {10.3390/jcm7090291}, volume = {7}, number = {9}, issn = {2077-0383}, title = {Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine}, keyword = {Duchenne muscular dystrophy, cardiomyopathy, cardiomyopathy in muscular dystrophy, dilated, dystrophin, heart failure, personalized medicine}, chapternumber = {E291} }
@article{article, author = {D’Amario, Domenico and Gowran, Aoife and Canonico, Francesco and Castiglioni, Elisa and Rovina, Davide and Santoro, Rosaria and Spinelli, Pietro and Adorisio, Rachele and Amodeo, Antonio and Perrucci, Gianluca and Borovac, Josip An\djelo and Pompilio, Giulio and Crea, Filippo}, year = {2018}, pages = {36}, DOI = {10.3390/jcm7090291}, chapter = {E291}, keywords = {Duchenne muscular dystrophy, cardiomyopathy, cardiomyopathy in muscular dystrophy, dilated, dystrophin, heart failure, personalized medicine}, journal = {Journal of clinical medicine}, doi = {10.3390/jcm7090291}, volume = {7}, number = {9}, issn = {2077-0383}, title = {Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine}, keyword = {Duchenne muscular dystrophy, cardiomyopathy, cardiomyopathy in muscular dystrophy, dilated, dystrophin, heart failure, personalized medicine}, chapternumber = {E291} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
    • Emerging Sources Citation Index (ESCI)
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font